McPherson R, Marcel Y
Lipid Research Laboratory, Royal Victoria Hospital, McGill University, Montreal, Canada.
Clin Cardiol. 1991 Feb;14(2 Suppl 1):I31-4. doi: 10.1002/clc.4960141305.
Cholesteryl ester transfer protein (CETP) and apolipoprotein E (apo E) play important roles in reverse cholesterol transport in humans. CETP transfers cholesteryl ester (CE) from high-density lipoprotein (HDL) to other lipoproteins, mainly very low-density lipoprotein (VLDL) remnants, which provide a vehicle for the delivery of HDL-derived CE to the liver via apo E or B/E receptors. Using a sensitive and specific radioimmunoassay, we have demonstrated that plasma concentrations of CETP vary dependent on gender, the concentration and composition of plasma lipoproteins, and dietary cholesterol intake. Plasma CETP appears to increase as an adaptive response to increased peripheral flux of cholesterol. Probucol therapy results in a significant increase in plasma CETP concentration, which may explain, in part, the marked effect of this agent on HDL concentration and composition.
胆固醇酯转运蛋白(CETP)和载脂蛋白E(apo E)在人体逆向胆固醇转运中发挥着重要作用。CETP将胆固醇酯(CE)从高密度脂蛋白(HDL)转移至其他脂蛋白,主要是极低密度脂蛋白(VLDL)残粒,后者通过apo E或B/E受体为将HDL衍生的CE转运至肝脏提供载体。通过一种灵敏且特异的放射免疫测定法,我们已证明CETP的血浆浓度因性别、血浆脂蛋白的浓度和组成以及膳食胆固醇摄入量而异。血浆CETP似乎作为对胆固醇外周通量增加的适应性反应而升高。普罗布考治疗导致血浆CETP浓度显著升高,这可能部分解释了该药物对HDL浓度和组成的显著影响。